News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Dr. Reddy's Laboratories (RDY) was downgraded by The Goldman Sachs Group, Inc. from "neutral" to "sell".

Nexus Pharmaceuticals Launches Cyclophosphamide Injection, 2.5 mL and 5 mL [Yahoo! Finance]

Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments [Yahoo! Finance]

Ozempic copies for $14 as the generic GLP-1 era starts in India [Los Angeles Times (CA)]

India's Zydus, Lupin sign deal to co-market Semaglutide injections [Yahoo! Finance]

1/22/2026

04:05 pm

RDY

-0.2%

BEAT

1/21/2026

04:06 pm

RDY

3.2%

BEAT

1/21/2026

07:06 am

RDY

3.3%

BEAT

7/24/2025

04:01 pm

RDY

0.4%

BEAT

Form 6-K DR REDDYS LABORATORIES For: Apr 24

Form 6-K DR REDDYS LABORATORIES For: Apr 24

Form 6-K DR REDDYS LABORATORIES For: Apr 16

Form 6-K DR REDDYS LABORATORIES For: Apr 14

Form 3 DR REDDYS LABORATORIES For: Apr 01 Filed by: MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}